Chris is a partner in the firm's Intellectual Property practice group who assists chemical, biotechnology and life sciences-based companies secure and protect intellectual property rights.

With an emphasis in chemical, biochemical, and biological patent preparation and prosecution, Chris counsels clients on freedom-to-operate issues, patent infringement issues, patentability and other due diligence issues. He also prepares non-infringement and invalidity opinions. In litigious situations, Chris provides strategic advice on prosecution and defense of these matters.

Chris’ experience involves a variety of subject matters, such as pediatric and adult nutritionals, small molecule design, pharmaceuticals, skin science and technology, bacteria-produced toxin inhibition, enzyme catalysis, microencapsulation, polymeric materials, heat transfer, semiconductor materials, electrochemical cells, hydrogen generation cells, herbicides, gene sequencing, electrochemistry and antibodies.